Author:
Chowdhury Neelanjan,Nanjappan Satheesh Kumar
Publisher
Springer Nature Singapore
Reference34 articles.
1. Cha Y, Erez T, Reynolds I, Kumar D, Ross J, Koytiger G, et al. Drug repurposing from the perspective of pharmaceutical companies. Br J Pharmacol. 2018;175(2):168–80.
2. Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074–82.
3. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, et al. DrugBank: a knowledgebase of drugs, drug actions, and drug targets. Nucleic Acids Res. 2008;36(Suppl_1):D901–6.
4. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, et al. DrugBank 3.0: a comprehensive resource for ‘omics’ research on drugs. Nucleic Acids Res. 2010;39(Suppl_1):D1035–41.
5. Speck-Planche A, Kleandrova VV. Demystifying artificial neural networks as generators of new chemical knowledge: antimalarial drug discovery as a case study. In: Cartwright HM, editor. Machine learning in chemistry. Cambridge: Royal Society of Chemistry; 2020. p. 398–423.